Publicaciones científicas

47 Publicaciones científicas disponibles

  • Radioembolization versus chemoembolization for unresectable hepatocellular carcinoma

    25 de octubre de 2018 | Revista: OncoTargets and Therapy

    Gardini AC (1), Tamburini E (2), Iñarrairaegui M (3), Frassineti GL (1), Sangro B (3).

    (1) Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
    (2) Department of Medical Oncology, Ospedale Infermi, Rimini, Italy.
    (3) Liver Unit, Clínica Universidad de Navarra-IDISNA and CIBEREHD, Pamplona, Spain.


  • Serum metabolites as diagnostic biomarkers for cholangiocarcinoma, hepatocellular carcinoma and primary sclerosing cholangitis

    16 de octubre de 2018 | Revista: Hepatology

    Banales JM (1,2,3), Iñarrairaegui M (2,4), Arbelaiz A (1), Milkiewicz P (5), Muntane J (2,6), Muñoz-Bellvis L (7), La Casta A (1), Gonzalez LM (7), Arretxe E (8), Alonso C (8), Martínez-Arranz I (8), Lapitz A (1), Santos-Laso A (1), Avila MA (2,9), Martínez-Chantar ML (2,8), Bujanda L (1,2), Marin JJG (2,10), Sangro B (2,4), Macias RIR (2,10).

    (1) Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain.
    (2) National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), Madrid, Spain.
    (3) IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.
    (4) Liver Unit, Clínica Universidad de Navarra-IDISNA, Pamplona, Spain.
    (5) Liver and Internal Medicine Unit, Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.
    (6) Department of General Surgery "Virgen del Rocío" University Hospital/IBiS/CSIC/ University of Seville, Spain.
    (7) Service of General and Gastrointestinal Surgery, University Hospital of Salamanca, Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.
    (8) Bizkaia Technology Park, Derio, Spain.
    (9) Division of Hepatology, Center for Applied Medical Research (CIMA), University of Navarra-IDISNA, Pamplona, Spain.
    (10) Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.


  • Immunotherapy of Hepatocellular Carcinoma: Facts and Hopes

    14 de noviembre de 2017 | Revista: Clinical Cancer Research

    Iñarrairaegui M (1), Melero I (2), Sangro B (3).

    (1) Liver Unit, Clínica Universidad de Navarra-IDISNA and CIBEREHD.
    (2) Centro virtual de Investigacion Biomedica en red de Oncologia, CIBERONC.
    (3) Liver Unit, Clínica Universidad de Navarra-IDISNA and CIBEREHD


  • Neutrophil-to-lymphocyte ratio predicts survival in European patients with hepatocellular carcinoma administered sorafenib

    5 de octubre de 2017 | Revista: Oncotarget

    Lué A (1,2), Serrano MT (1,2), Bustamante FJ (3), Iñarrairaegui M (4,5), Arenas JI (6), Testillano M (3), Lorente S (1,2), Gil C (3), de la Torre M (4), Gomez A (6), Sangro B (4,5)

    (1) Department of Gastroenterology, Hospital Clínico Universitario Lozano Blesa, 50009, Zaragoza, Spain.
    (2) Instituto de Investigación Sanitaria (IIS) Aragón, 50009, Zaragoza, Spain.
    (3) Department of Gastroenterology, Hospital Universitario Cruces, Plaza de Cruces, 48903, Barakaldo, Spain.
    (4) Liver Unit, Clinica Universidad de Navarra-IDISNA, 31008, Pamplona, Spain.
    (5) Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD), 31008, Pamplona, Spain.
    (6) Department of Gastroenterology, Hospital Universitario Donostia, Begiristain Doktorea Pasealekua, 20014, San Sebastian, Spain.

No hay más publicaciones científicas

No hay más páginas para cargar